Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Convergent Dental

Request full access

Convergent Dental develops a computer-guided, laser-based drilling and cutting system for dentists

Waltham, United StatesFounded 2011Biotech & Life Sciences

About Convergent Dental

Convergent Dental, Inc. operates as a privately held dental equipment and technology company, having been founded by Michael Cataldo in 2011 with the objective of addressing patient fear of dental procedures. Cataldo, a serial entrepreneur with a background in healthcare software, previously founded MediVation, which was later acquired by McKesson. After years of development, the company introduced its flagship product in 2013. Robert L. Gershon, a seasoned executive in the medical technology sector with prior leadership roles at companies like Mauna Kea Technologies and Bovie Medical, took over as CEO in July 2022 following Cataldo's retirement.

The company's core business is the sale of its Solea® All-Tissue Dental Laser system to dental professionals, including solo practitioners, dental service organizations (DSOs), and dental schools. This system is designed to improve practice efficiency, clinical outcomes, and the overall patient experience. Revenue is generated through the sale of the Solea system, with the company also offering training, education programs, and customer support to ensure effective implementation. Strategic partnerships with distributors like Patterson Dental expand the company's market reach across the United States and Canada.

Solea is a computer-aided carbon dioxide (CO2) laser system distinguished by its unique 9.3-micron wavelength, which is highly absorbed by both hydroxyapatite (enamel) and water (soft tissue). This allows the laser to vaporize enamel and ablate soft and osseous tissue with high speed and precision, a key differentiator from other laser technologies that may slowly chip enamel or are limited to soft tissue applications. It is the only CO2 laser cleared by the FDA for all-tissue indications. For dentists, this translates to performing a wide array of procedures—from cavity preparations and gum contouring to treating snoring—often without the need for anesthetic injections, drills, or sutures. This capability enables dentists to perform more same-day and multi-quadrant procedures, significantly boosting practice productivity. For patients, the experience is quieter and avoids the vibration of a drill, reducing anxiety and discomfort. The system also includes a non-surgical treatment for palatal snoring, Solea® Sleep, which works by tightening tissue in the soft palate in a simple five-minute procedure.

Source: Dealroom company data

At a glance

Status
Operational
Employees
110
Open positions
None listed
Dealroom signal
43.8/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2C

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEOther financing Apr 2023 $5M — Undisclosed ↗
LATE VCOther financing Apr 2023 $5M $219M Arboretum Ventures · Gund Investment ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Convergent Dental website traffic

Latest recorded traffic for Convergent Dental is 5.9K monthly website visits, up 78.8% over the last three months. Convergent Dental's team grew 0.9% over the past year.

Latest monthly visits5.9K 3-month web change+78.8% 1-year team growth+0.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Convergent Dental in the Waltham ecosystem

Live from Dealroom

The Convergent Dental office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

  • LRVHealth
  • Gund Foundation
  • Arboretum Ventures
  • Long River Ventures
  • Gund Investment
  • Trinity Capital

Other known investors1 additional known investor

  • University of California, San Francisco
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States93.9%
🇨🇦 Canada6.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Convergent Dental on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Convergent Dental’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.